SOLV
Solventum Corporation
Solventum Corporation insider trading
Every time one of SOLV's executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
SEC Form 4 data, Q3 2024 to Q2 2026
SOLV insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 2 insiders traded SOLV on the open market: 1 purchase worth $100.3K and 1 sale worth $646.4M. In the last four quarters alone: 1 purchase ($100.3K) and 1 sale ($646.4M), by 2 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | +$100.3K1 buy | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | −$646.4M1 sale | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$100.3K of SOLV by Wendell Amy McBride (Director) on Mar 10, 2026.
- Largest sale
- −$646.4M of SOLV by 3m Co (10% Owner) on Aug 15, 2025.
Open-market transactions through Jun 30, 2026most recent first
Wendell Amy McBride
Director
+$100.3K
Mar 10, 2026
1,475 sh · $68.03
3m Co
10% Owner
−$646.4M
Aug 15, 2025
8,800,000 sh · $73.45
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 10, 2026 | Wendell Amy McBrideDirector | 1,475 | $68.03 | +$100.3K |
| Aug 15, 2025 | 3m Co10% Owner | 8,800,000 | $73.45 | −$646.4M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
After insiders bought SOLV
What the stock actually did in the 90 days following each open-market purchase
Don't check SOLV — let it ping you
Get told the moment an insider moves on SOLV
Pro watches Solventum Corporation for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add SOLV to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read SOLV insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- How much SOLV stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 2 Solventum Corporation insiders made 1 open-market purchase worth $100.3K and 1 sale worth $646.4M. In the four quarters to Jun 30, 2026: 1 purchase ($100.3K) and 1 sale ($646.4M). The largest purchase was Wendell Amy McBride buying $100.3K on Mar 10, 2026. The largest sale was 3m Co selling $646.4M on Aug 15, 2025.
- Where does SOLV insider trading data come from?
- From the Form 4 filings Solventum Corporation's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.